Ian Thomas Nisbet
Director/Board Member at SOLAGRAN LIMITED
Profile
Ian Thomas Nisbet is the founder of Afandin Pty Ltd.
He currently holds multiple positions including Chairman at vivoPharm Pty Ltd, Non-Executive Director at Prenolica Ltd, Non-Executive Director at Velacor Therapeutics Pty Ltd, and Deputy Director at Australian Institute For Bioengineering & Nanotechnology.
In the past, he served as Chief Executive Officer at Meditech Research Ltd, Chief Executive Officer & Managing Director at Xenome Ltd, Senior Director at Millennium Pharmaceuticals, Inc, Non-Executive Director at Diversa Pty Ltd, Principal at CSL Ltd, Vice President at ChemGenex Pharmaceuticals Pty Ltd, and Vice-President-Oncology at ChemGenex Pharmaceuticals, Inc. Dr. Nisbet received his undergraduate degree from the University of Melbourne and his doctorate from Monash University.
Ian Thomas Nisbet active positions
| Companies | Position | Start |
|---|---|---|
| SOLAGRAN LIMITED | Director/Board Member | 2014-09-30 |
Afandin Pty Ltd.
 Afandin Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Afandin Pty Ltd. operates as a corporate advisory company. The firm’s services include operational support, corporate development strategic support, product development strategic support, finance and international referral network. The company was founded by Ian Thomas Nisbet and Anthony Filippis and is headquartered in Camberwell, Australia. | Founder | 2009-08-26 |
vivoPharm Pty Ltd.
 vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Chairman | 2011-10-30 |
Velacor Therapeutics Pty Ltd.
 Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | Director/Board Member | - |
| Australian Institute For Bioengineering & Nanotechnology | Corporate Officer/Principal | - |
Former positions of Ian Thomas Nisbet
| Companies | Position | End |
|---|---|---|
| DIVERSA LIMITED | Director/Board Member | 2008-07-01 |
Meditech Research Ltd.
 Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Chief Executive Officer | 2006-09-25 |
| CSL LIMITED | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Ian Thomas Nisbet
| University of Melbourne | Undergraduate Degree |
| Monash University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CSL LIMITED | Health Technology |
| Private companies | 12 |
|---|---|
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Health Technology |
Diversa Pty Ltd.
 Diversa Pty Ltd. Investment ManagersFinance Diversa Pty Ltd. engages in the provision of investment management and financial services. It operates through Superannuation Services and Trustee Services segments. The Superannuation Services segment provides administration and promotion services to superannuation funds and the issue of group risk products. The Trustee Services segment involves in the third party superannuation trustee services and investment services. The company was founded by Matthew Morgan and Angus Craig on July 03, 1997 and is headquartered in Melbourne, Australia. | Finance |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals Pty Ltd. develops pharmaceutical products. It develops small molecules with new mechanisms of action to treat malignancies with significant unmet medical needs. The firm also develops personalized oncology, obesity and diabetes medicines. The company was founded in September 1958 and is headquartered in Geelong, Australia. | Health Technology |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
Verva Pharmaceuticals Ltd.
 Verva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Verva Pharmaceuticals Ltd. developed therapies to treat diabetes. Its products include insulin sensitizers, insulin secretagogues, fat formation inhibitors for the prevention, treament of obesity, drug-induced weight gain and insulin secretion modulators. The company was founded in 1996 and was headquartered in Geelong, Australia. | Health Technology |
ChemGenex Pharmaceuticals, Inc.
 ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Afandin Pty Ltd.
Afandin Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Afandin Pty Ltd. operates as a corporate advisory company. The firm’s services include operational support, corporate development strategic support, product development strategic support, finance and international referral network. The company was founded by Ian Thomas Nisbet and Anthony Filippis and is headquartered in Camberwell, Australia. | Commercial Services |
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology vivoPharm Pty Ltd. provides proprietary preclinical oncology services. It offers integrated service in different disease areas to the biotechnology and pharmaceutical industries. It specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug Applications (IND) filing. The company was founded by Ralf Brandt and Sabine Brandt in 2003 and is headquartered in Bundoora, Australia. | Health Technology |
Velacor Therapeutics Pty Ltd.
Velacor Therapeutics Pty Ltd. Medical SpecialtiesHealth Technology Velacor Therapeutics Pty Ltd. develops novel therapeutics for prostate cancers. The firm offers novel treatment for prostate, glioblastoma, ovarian and lung cancer. The company was founded by Christopher Hovens in 2005 and is headquartered in Parkville, Australia. | Health Technology |
| Australian Institute For Bioengineering & Nanotechnology | |
Prenolica Ltd.
 Prenolica Ltd. Pharmaceuticals: OtherHealth Technology Prenolica Ltd. engages in the research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions. It products include Ropern, Tiga, Bio effective Gel and Siberian Red. The company was founded in 1995 and is headquartered in Melbourne, Australia. | Health Technology |
- Stock Market
- Insiders
- Ian Thomas Nisbet
